J

Johannes F.E. Mann

Katholische Stiftungshochschule München

ORCID: 0000-0002-3154-5332

434 papers and 47.8k citations.

PubIndex Score98Top 2%How it's scored

434Publications

47.8kTotal Citations

First publication: 1977First senior author: 1978

Top publicationsby citations

Dapagliflozin in Patients with Chronic Kidney Disease

Hiddo J.L. Heerspink, David C. Wheeler, Bergur V. Stefánsson et al.|New England Journal of Medicine|2020

Cited by 5.2k

Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes

Vlado Perkovic, Richard Pratley, Katherine R. Tuttle et al.|New England Journal of Medicine|2024

Cited by 1.5k

Urinary Sodium and Potassium Excretion and Risk of Cardiovascular Events

Martin O’Donnell, Roland E. Schmieder, Salim Yusuf et al.|JAMA|2011

Cited by 566

Rationale and protocol of the Dapagliflozin And Prevention of Adverse outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial

Hiddo J.L. Heerspink, Rey Isidto, Bergur V. Stefánsson et al.|Nephrology Dialysis Transplantation|2019

Cited by 216

Effects of semaglutide with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic kidney disease in the FLOW trial

Johannes F.E. Mann, Katherine R. Tuttle, Peter Rossing et al.|Nature Medicine|2024

Cited by 152

Indexing the rest of 434 publications…